bc006
mAbexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 26, 2021 (NCT05212896)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05211440 | N/A | Jan 18, 2022 | BIO-CAT Inc., University of Illinois |
| NCT05212896 | Phase 1 | Nov 26, 2021 | Guilin Sanjin, Sichuan University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BIO-CAT Inc. | For profit | 1 | 0 | 1 | 2022 |
| Guilin Sanjin | For profit | 1 | 1 | 1 | 2021 |
| Sichuan University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Illinois | Academic/Hospital | 1 | 1 | 1 | 2022 |
4 organizations
Page 1 / 1